BioAtla (BCAB) Accumulated Depreciation & Amortization (2020 - 2025)
BioAtla's Accumulated Depreciation & Amortization history spans 6 years, with the latest figure at $5.3 million for Q4 2025.
- For Q4 2025, Accumulated Depreciation & Amortization fell 24.2% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 24.2%, while the annual FY2025 figure was $5.3 million, 24.2% down from the prior year.
- Accumulated Depreciation & Amortization reached $5.3 million in Q4 2025 per BCAB's latest filing, down from $7.4 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $7.4 million in Q3 2025 to a low of $3.4 million in Q1 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $5.6 million, with a median of $5.8 million recorded in 2023.
- Peak YoY movement for Accumulated Depreciation & Amortization: surged 38.66% in 2021, then dropped 24.2% in 2025.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $4.3 million in 2021, then grew by 26.0% to $5.4 million in 2022, then increased by 13.31% to $6.1 million in 2023, then increased by 15.22% to $7.0 million in 2024, then decreased by 24.2% to $5.3 million in 2025.
- Per Business Quant, the three most recent readings for BCAB's Accumulated Depreciation & Amortization are $5.3 million (Q4 2025), $7.4 million (Q3 2025), and $7.3 million (Q2 2025).